NLRX1 and colitis: To characterize the selectivity of the anti-inflammatory mechanism of PUA in the gut mucosa as NLRX1-dependent, WT mice and Nlrx1-/- mice were challenged with six days of DSS-induced colitis and treated with either PUA or PBS, as a control, daily via oral gavage.